Assenagon Asset Management S.A. Voyager Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $37.1 Billion
- Q1 2024
A detailed history of Assenagon Asset Management S.A. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 28,896 shares of VYGR stock, worth $217,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,896
Previous 17,960
60.89%
Holding current value
$217,297
Previous $151,000
78.15%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VYGR
# of Institutions
134Shares Held
34.2MCall Options Held
35.3KPut Options Held
63K-
Armistice Capital, LLC New York, NY4.67MShares$35.1 Million0.59% of portfolio
-
Black Rock Inc. New York, NY4.4MShares$33.1 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$29.5 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$24.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$17.2 Million0.1% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $291M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...